Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silo Pharma Inc
(NQ:
SILO
)
0.9101
+0.0479 (+5.56%)
Streaming Delayed Price
Updated: 1:23 PM EDT, Jul 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
40,117
Open
0.8850
Bid (Size)
0.9100 (20)
Ask (Size)
0.9250 (2)
Prev. Close
0.8622
Today's Range
0.8800 - 0.9350
52wk Range
0.8410 - 3.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters License Agreement with Columbia University for Lead Candidate Targeting PTSD, Stress-Induced Anxiety Disorders
July 08, 2024
Via
Investor Brand Network
Exposures
Product Safety
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
July 08, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Performance
YTD
-40.12%
-40.12%
1 Month
-22.87%
-22.87%
3 Month
-57.47%
-57.47%
6 Month
-36.80%
-36.80%
1 Year
-56.67%
-56.67%
More News
Read More
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
June 26, 2024
Via
Investor Brand Network
Why Silo Pharma Stock Is Down Over 30%
June 05, 2024
Via
Benzinga
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
June 26, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 11, 2024
Via
Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic
June 07, 2024
Via
Investor Brand Network
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
June 07, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 06, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results
June 05, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 05, 2024
Via
Benzinga
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M
June 05, 2024
Via
Investor Brand Network
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 05, 2024
Via
Benzinga
Gold Gains 1%; ISM Services PMI Surges In May
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 05, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, Anxiety
June 04, 2024
Via
Investor Brand Network
Exposures
Product Safety
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
June 04, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma’s (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
June 04, 2024
Via
AB Newswire
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares ‘Significant Development’ in Depression Study Showing Potential to Extend Remission Period, Prevent Relapse
May 21, 2024
Via
Investor Brand Network
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention
May 21, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Announces Participation in FDA Event Exploring Emerging Therapeutic Interest in Ketamine
May 14, 2024
Via
Investor Brand Network
Exposures
Product Safety
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
May 14, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.